TICKERNOMICS Sign up
Last Update: 2024-12-27 15:29:10
BullFrog AI Holdings Inc. ( BFRG )
2.29USD
Sector:
Healthcare
Industry:
Health Information Services
Country:
1y
3y
5y
10y
Historical Returns*:
SPY
27.80%
-25.41%
BFRG
SPY
32.66%
BFRG
0.00%
SPY
108.59%
BFRG
0.00%
SPY
302.52%
BFRG
0.00%
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
18.61
14.37
0.23
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
-2.83
214.54
4.87
-22.27
0.00
-1.97
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
-114020.77
-25.00
-105653.12
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
4.32
-4237.86
3133.65
0.00
Other Earnings and Cash Flow Stats:
BullFrog AI Holdings Inc. ( BFRG ) Net Income TTM ($MM) is -6.58
BullFrog AI Holdings Inc. ( BFRG ) Operating Income TTM ($MM) is -6.80
BullFrog AI Holdings Inc. ( BFRG ) Owners' Earnings Annual ($MM) is 0.00
BullFrog AI Holdings Inc. ( BFRG ) Current Price to Owners' Earnings ratio is 0.00
BullFrog AI Holdings Inc. ( BFRG ) EBITDA TTM ($MM) is -6.80
BullFrog AI Holdings Inc. ( BFRG ) EBITDA Margin is -105653.12%
Capital Allocation:
BullFrog AI Holdings Inc. ( BFRG ) has paid 0.00 dividends per share and bought back -2.03019 million shares in the past 12 months
BullFrog AI Holdings Inc. ( BFRG ) has increased its debt by 0.0 million USD in the last 12 months
Capital Structure:
BullFrog AI Holdings Inc. ( BFRG ) Interest-bearing Debt ($MM) as of last quarter is 0
BullFrog AI Holdings Inc. ( BFRG ) Annual Working Capital Investments ($MM) are -1
BullFrog AI Holdings Inc. ( BFRG ) Book Value ($MM) as of last quarter is 3
BullFrog AI Holdings Inc. ( BFRG ) Debt/Capital as of last quarter is 0%
Other Balance Sheet Stats:
BullFrog AI Holdings Inc. ( BFRG ) has 4 million in cash on hand as of last quarter
BullFrog AI Holdings Inc. ( BFRG ) has 0 million of liabilities due within 12 months, and long term debt 0 as of last quarter
BullFrog AI Holdings Inc. ( BFRG ) has 8 common shares outstanding as of last quarter
BullFrog AI Holdings Inc. ( BFRG ) has 0 million USD of preferred stock value
Academic Scores:
BullFrog AI Holdings Inc. ( BFRG ) Altman Z-Score is 5.52 as of last quarter
BullFrog AI Holdings Inc. ( BFRG ) Piotroski Score is 2.00 as of last quarter
Corporate Governance:
BullFrog AI Holdings Inc. ( BFRG ) largest shareholder is owning shares at 0.00 ($MM) value
Singh Vininder(an insider) Sold 5695 shares of BullFrog AI Holdings Inc. ( BFRG ) for the amount of $14727.27 on 2024-10-09
29.20% of BullFrog AI Holdings Inc. ( BFRG ) is held by insiders, and 3.48% is held by institutions
BullFrog AI Holdings Inc. ( BFRG ) went public on 2023-02-13
Other BullFrog AI Holdings Inc. ( BFRG ) financial metrics:
FCF:-5.36
Unlevered Free Cash Flow:-5.56
EPS:-0.87
Operating Margin:-114020.77
Gross Profit Margin:-25.00
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:-184.50
Beta:0.00
Buffet's Owners Earnings:0.00
Price to Owner's Earnings:0.00
About BullFrog AI Holdings Inc. ( BFRG ) :
Bullfrog AI Holdings, Inc., through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. The company offers bfLEAP, an AI/ML platform for the analysis of preclinical and/or clinical data. It also has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for the use of a formulation of Mebendazole for the treatment of human cancer or neoplastic disease. The company was founded in 2017 and is based in Gaithersburg, Maryland.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.